- Conditions
- Rheumatoid Arthritis
- Interventions
- SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System
- Device
- Lead sponsor
- SetPoint Medical Corporation
- Industry
- Eligibility
- 22 Years to 75 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2026
- U.S. locations
- 4
- States / cities
- Aventura, Florida • Zephyrhills, Florida • Great Neck, New York + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–4
of 4
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Implant Procedure, Disease-Modifying Therapies (DMTs), Active stimulation, Non-active stimulation
- Procedure · Drug · Device
- Lead sponsor
- SetPoint Medical Corporation
- Industry
- Eligibility
- 22 Years to 60 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 9
- States / cities
- Irvine, California • Atlanta, Georgia • Baltimore, Maryland + 6 more
- Conditions
- Rheumatoid Arthritis
- Interventions
- SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System
- Device
- Lead sponsor
- SetPoint Medical Corporation
- Industry
- Eligibility
- 22 Years to 75 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 4
- States / cities
- Aventura, Florida • Zephyrhills, Florida • Great Neck, New York + 1 more
- Conditions
- Rheumatoid Arthritis
- Interventions
- Implant Procedure, Conventional Synthetic DMARD, Active stimulation, Non-active stimulation
- Procedure · Drug · Device
- Lead sponsor
- SetPoint Medical Corporation
- Industry
- Eligibility
- 22 Years to 75 Years
- Enrollment
- 243 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 42
- States / cities
- Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 37 more